文献速递慢性肾脏病血液净化与透析肾移植

澳大利亚慢性肾脏病筛查与监测:过去、现在和未来

CKD Screening and Surveillance in Australia: Past, Present, and Future.
PubMed 文献 · Kidney Int Rep · 2017-10-06

该文回顾了澳大利亚慢性肾脏病(CKD)筛查与监测的发展历程。过去研究聚焦普通人群和高危人群筛查,促成国家卫生政策;目前除ANZDATA登记透析移植患者外,非透析CKD长期监测刚起步,CKD.Queensland和西澳肾脏病数据库可填补空白;2015年CKD卓越中心和2016年BEAT-CKD的建立可能改变未来。

要点

  • 2002年NKF CKD分类和2006年KDIGO建议被澳大利亚采纳并纳入实践指南。
  • 过去筛查研究确认CKD是澳大利亚公共卫生问题,推动国家政策制定。
  • 目前非透析CKD长期监测刚起步,CKD.Queensland和西澳数据库可提供协作研究机会。

核心结论

  • 澳大利亚CKD筛查与监测从普通人群和高危人群筛查研究起步,已推动国家政策,未来依托CKD卓越中心和BEAT-CKD等平台有望加强非透析CKD长期监测与研究。

研究设计与样本

  • 本文为综述,回顾澳大利亚CKD筛查与监测的过去、现在和未来,涉及2002年NKF分类、2006年KDIGO建议、ANZDATA登记、CKD.Queensland、西澳肾脏病数据库、2015年CKD卓越中心和2016年BEAT-CKD。

主要发现

  • 过去澳大利亚CKD研究聚焦普通人群及CKD高危个体筛查,信息促使认识到CKD负担是公共卫生问题并贡献于国家卫生政策和优先事项制定。
  • 目前除ANZDATA报告接受肾脏替代治疗(RRT)的CKD患者外,描述非RRT CKD人群自然史的长期监测仅近期开始。
  • CKD.Queensland和西澳肾脏病数据库能填补非透析CKD监测空白并提供协作研究机会。

关键数值与推荐

  • 2002年国家肾脏基金会CKD分类和2006年KDIGO建议被国际社会包括澳大利亚强烈认可并纳入CKD实践指南。

临床怎么用

  • 肾内科医生可关注CKD.Queensland和西澳肾脏病数据库等平台,参与非透析CKD协作研究。
  • 利用ANZDATA了解透析移植患者情况,同时认识非透析CKD长期监测的不足。

局限性

  • 本文为综述,未报告原始研究数据、样本量或统计值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Chronic kidney disease (CKD) was largely a hidden health problem until the publication of an internationally agreed approach to its identification, monitoring, and treatment. The 2002 National Kidney Foundation CKD classification and the subsequent 2006 Kidney Disease Improving Global Outcomes (KDIGO) recommendations are powerful tools for translating thinking about CKD into clinical practice. These guidelines were strongly endorsed by the international community, including Australia, and were incorporated into CKD practice guidelines. In the past, CKD research studies in Australia focused on screening the general population, and more specifically, individuals at risk for CKD. Information from these studies led to the recognition that the CKD burden in Australia is a public health problem and contributed to the development of national health policies and priorities. At present, apart from the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) that reports on CKD patients undergoing renal replacement therapy (RRT), long-term surveillance to describe the natural history of the CKD population not on RRT has only recently started. Entities such as CKD. Queensland and the Western Australian Nephrology Database are able to fill the gap and provide opportunities for collaborative research of CKD in Australia. Establishment of a National Health and Medical Research Centre-funded CKD Centre of Excellence in 2015 and the Better Evidence and Translation-Chronic Kidney Disease in 2016 are likely to change the future of CKD surveillance and research in Australia.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Venuthurupalli SK, Hoy WE, Healy HG, et al. CKD Screening and Surveillance in Australia: Past, Present, and Future. Kidney Int Rep. 2017. PMID: 29340312. doi:10.1016/j.ekir.2017.09.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。